The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
SINGLE
Enrollment
66
Investigational silicone hydrogel contact lens worn on a daily wear basis
Air Optix Aqua contact lens worn on a daily wear basis
Bausch & Lomb, Incorporated
Rochester, New York, United States
Visual Acuity
Distance high contrast logMAR lens visual acuity (VA) between the Air Optix Aqua lens and the Test Lens at Dispensing and at 1-Week Follow-up.
Time frame: Dispensing & 1-week follow up
Slit Lamp Findings
Measured on a scale of 0-4 where 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe for edema, microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization and corneal infiltrates.
Time frame: 1 week
Comfort
At 1-Week Follow-up, participants rated lens comfort on a scale of 0 to 100, with 100 being the most favorable score.
Time frame: 1 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.